Emil Parente is a WMer with a real past, and he is happy to share it with others, particularly those who are newly diagnosed.
Mail-in DNA tests may not provide enough information to people looking for answers about their genetic predisposition to cancer.
Jae Park, MD, Memorial Sloan Kettering Cancer Center, explains CAR T-cell therapy, which is currently being investigated in patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, and non-Hodgkin lymphoma.
Jill Stopfer, MS, CGC, Senior Genetic Counselor, Abramson Cancer Center, University of Pennsylvania, discusses the benefits of multigene panel testing.
Kevin Hughes, MD, FACS, breast surgeon, Massachusetts General Hospital, discusses the impact of lumpectomies on elderly patients with breast cancer.
Jean Ellsworth-Wolk, MS, RN, AOCNS, discusses the importance of nagivating survivorship for adolescent and young adult patients with cancer.
Tips to stay healthy this winter from Genny's Hope Foundation
Alice P. Chen, MD, Early Clinical Trials Development Program, National Cancer Institute, provides an overview of the NCI-MATCH trial.
The FDA approved atezolizumab plus cobimetinib and vemurafenib for the treatment of patients with BRAF V600 mutation-positive advanced melanoma.
Tracey L. Evans, MD, associate professor, clinical medicine, Abramson Cancer Center, University of Pennsylvania Health System, gives advice to oncology nurses on how to manage side effects in patients with lung cancer.
Kathy Jo Gutgsell, RN, MT-BC, music therapist at University Hospitals Seidman Cancer Center talks about how music can help patients with cancer.
Leslie R. Schover, founder of the Will2Love online resources, discusses the sexual health and fertility issues that can come as a result of cancer treatment, and how these issues can be managed. Join us for our #CureConnect tweetchat, Tuesday 2/21, on this topic.
Cristi Radford, MS, CGC, from the Sarasota Memorial Hospital, discusses examining cancer gene panels using next generation sequencing for patients with ovarian cancer.
Chemotherapy-induced peripheral neuropathy is a common side effect in patients with cancer and nurses are essential to helping patients to manage this condition.
This college admissions essay, penned by 17-year-old Samantha Stephens, offers a powerful and poignant reminder of the impact a cancer diagnosis can have on a patient's family and caregivers.
Grant Williams, MD, clinical instructor and research fellow at the University of North Carolina, Chapel Hill, discusses sarcopenia in patients with cancer.
Oncology nurses are the first line of defense when it comes to a patient's psychosocial needs, but they don't often have the time to directly attend to them. Which is where support groups can come in to help.
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
Palliative care should address the unique symptom profile of gynecologic cancer and be tailored to individual socioeconomic environments.
Amy Hansen was diagnosed with Ovarian cancer while pregnant at 12 weeks. Amy's son, Gavin Michael, was born in 2013.
Registries, large databases of patient information collected in a systematic, standardized fashion, most often focus on biologic measures, such as pathology, radiology, and laboratory results, to track incidence and prevalence of disease as well as causative factors.
Talking about end of life during what should be the happiest time of year can be difficult. Nurses can help ease these discussions with patients and their families.
Mary S. McCabe, RN, MA, discusses an evaluation of nurse practitioner-led survivorship care.
The terminology that oncology nurses use to describe opioid addiction can affect patient care.
William Wierda, MD, PhD, medical director, Leukemia Center, The University of Texas MD Anderson Cancer Center, discusses treatment of chronic lymphocytic leukemia (CLL) in young and elderly patients.
It is imperative that nurses and other health care professionals not only recognize the disparities in preventive screenings but become part of the solution. Early detection and cancer treatment must be accessible for those with disabilities, as it can help save lives.
Marguerite Regan, PhD, was diagnosed with Waldenstrom's macroglobulinemia in 1995 and shares practical wisdom from her experiences, including reminding patients that WM isa treatable illness, not an end game.
Newly described research reports an upward trend in the proportion of patients with NSCLC classified as never-smokers.